Gender Care Failures at Brighton GP Clinic Put Dozens of Children at Risk
Investigation Reveals Systemic Gaps in Treatment Protocols
Dozens of children put at risk – Dozens of children were put at risk due to gender care failures at a Brighton GP clinic, according to a recent NHS inquiry. The investigation, which spanned 12 months, found that 78 young patients received puberty-blocking drugs and cross-sex hormones without proper assessments, raising serious concerns about the safety of their care. These medications, which can alter physical development and affect long-term health, were prescribed by clinicians at WellBN, a practice that opened its transgender health hub in Brighton in 2020. With over 2,000 patients reported by the previous year, many from outside the city, the clinic aimed to address long waiting times for specialist gender services in England. However, the findings suggest that the rush to provide care may have compromised the well-being of minors.
The inquiry, led by five independent clinicians from NHS Sussex, highlighted critical lapses in the clinic’s approach to treating children under 18. These included insufficient diagnostic evaluations, lack of parental involvement in some cases, and an overreliance on rapid decision-making. As a result, NHS England has instructed the clinic to pause new prescriptions for minors and referred several clinicians to medical regulators. One doctor named in the report has been suspended from NHS work while further investigations are underway. The report underscores the importance of balancing rapid access to care with rigorous clinical standards, particularly for vulnerable young patients.
Medication Prescribed Without Adequate Oversight
Between February 2023 and December 2025, more than 20 children received gender-related medications without face-to-face appointments. This included the prescription of puberty-delaying drugs to 44 children aged 16 and under, with 12 under the age of 13. Notably, an 11-year-old was among those treated with cross-sex hormones, which can cause irreversible changes such as altered voice pitch or breast development. The lack of direct consultations raised questions about the thoroughness of the clinic’s protocols and whether young patients were fully informed of the potential long-term effects of these treatments.
“Under no circumstances should this have happened,” said Dr Christopher Tibbs, regional medical director for NHS England. “Young people were put at a high risk of harm because clinicians provided specialist diagnosis, care and treatment they were neither qualified nor commissioned to deliver.”
The report emphasized that while the clinic sought to address gender care needs, it failed to implement adequate safeguards. For example, some children received hormone therapy without their parents’ consent, with one father describing the process as a “medical scandal.” The findings have sparked debates about the role of general practitioners in delivering specialist gender care and the need for clearer guidelines to prevent similar incidents.
Impact on Families and Relationships
The inquiry has also shed light on the broader consequences for families and relationships. Parents of affected children expressed distress over the clinic’s approach, with one father recounting how his 16-year-old son was prescribed hormones without his approval. Another parent shared that the emotional strain of the treatment led to suicidal thoughts. The report noted that 53 of the 78 cases involved possible neuro-developmental issues, underscoring the need for holistic assessments that consider both physical and psychological health. Rachel Cashman, co-founder of PSHE Brighton, warned that the focus on gender medication risked overshadowing children’s overall health needs, especially for those with conditions like autism or ADHD.
Parents and school governors in Brighton have been vocal about their concerns, highlighting how the clinic’s procedures disrupted family dynamics. A group of local stakeholders began raising alarms in 2023 as part of a broader campaign on health education. The BBC interviewed three anonymized parents, each detailing the stress and confusion caused by the treatment process. One father, currently pursuing legal action, mentioned his son had forged his mother’s signature to access hormone therapy, with oestrogen prescribed without parental knowledge. These stories emphasize the urgency of ensuring that children’s health decisions are made with full family input and medical transparency.
Broader Implications for NHS Gender Services
The findings from the inquiry have sparked a wider discussion about the quality of gender care within the NHS. While WellBN was established to reduce waiting times for specialist services, the report suggests that the clinic may have prioritized speed over safety. This has raised questions about the training and qualifications of staff involved in administering gender-related treatments, particularly for children. The NHS has acknowledged the need to strengthen oversight and improve documentation to prevent future risks. Medical regulators are now reviewing the cases to determine whether further disciplinary actions are necessary.
Experts have called for a more structured approach to gender care, especially for minors. They argue that while early intervention can be beneficial, it must be accompanied by comprehensive assessments and informed consent processes. The report also highlights the importance of multidisciplinary teams, including paediatricians, psychologists, and social workers, to ensure holistic care. Parents and advocacy groups are urging the NHS to adopt standardized protocols that protect children’s health while addressing their gender care needs. This incident serves as a reminder of the delicate balance required when treating young patients with complex medical and emotional considerations.
As the inquiry concludes, the focus remains on how to prevent such failures in the future. The NHS is working with WellBN to review its practices and implement changes that align with clinical best practices. Families affected by the treatment have also called for greater accountability, emphasizing the need for transparency in medical decisions. With the number of children put at risk now clear, the debate over the safety and efficacy of gender care in primary clinics is expected to continue, shaping policies and practices for years to come.
